Ning Zou
Inventor
Stats
- 11 US patents issued
- 38 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 11 US Patents Issued
- 38 US Applications Filed
- 131 Total Citation Count
- Feb 14, 2024 Most Recent Filing
- Mar 30, 2004 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ZOU, NING | 1
| 2012
|
| TAISHO PHARMACEUTICAL CO., LTD. | 1
| 2004
|
| ARENA PHARMACEUTICALS, INC. | 1
2 5 4 3 4 3 2 2 | 2004
2007 2009 2012 2013 2014 2015 2016 2017 |
| AMBRX, INC. | 1
| 2013
|
Inventor Addresses
| Address | Duration |
|---|---|
| Austin, TX, US | Feb 06, 14 - Nov 04, 14 |
| Beijing, CN | Oct 19, 17 - Mar 26, 19 |
| La Jolla, CA, US | Mar 18, 21 - Nov 03, 22 |
| SAN DIEGO, CA, US | Oct 25, 12 - Oct 25, 12 |
| San Diego, CA | Sep 08, 05 - Sep 08, 05 |
| San Diego, CA, US | Aug 06, 09 - Jan 14, 25 |
| San Diego, IN, US | Apr 21, 15 - Apr 21, 15 |
| West Lafayette, IN, US | Aug 16, 18 - Oct 15, 20 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 25 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 11 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 8 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| RE50267 | 2025 | Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto | 0 |
| 2025/0009,693 | 2025 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | 0 |
| 2023/0404,954 | 2023 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | 1 |
| 2023/0121,825 | 2023 | MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | 1 |
| 2022/0347,306 | 2022 | SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.